Visiongain Report Researches Growth Opportunities Within The $424bn Generic Drugs Market

Growth in Leading Regional and National Markets – North America, Europe,Asia-Pacific, Middle-East & Africa, Latin America, US, Canada, Germany, France, UK, Italy, Spain, India, China, Australia,South Korea, Japan, South Africa, Saudi Arabia, U.A.E, Brazil, Argentina, Mexico, Teva, Novartis, Mylan, Pfizer, Abbott, Sun Pharma, Aspen, Fresenius Kabi, Sanofi, Dr. Reddy’s Laboratories Limited, Apotex

The generic drugs market is estimated to have reached $257.3bn in 2018 and is expected to grow at a CAGR of 8.8% in the first half of the forecast period. Asia-Pacific held 31% of the generic drugs market in 2018.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 246-page report you will receive 66 tables and 84 figures– all unavailable elsewhere.

The 246-page report provides clear detailed insight into the generic drugs market. Discover the key drivers and challenges affecting the market.

By ordering and reading Visiongain’s brand-new report today you stay better informed and ready to act. – PR Newswire